Retatrutide is the most potent triple GLP-1/GIP/Glucagon agonist available for metabolic research. Phase 3 clinical trials show weight reduction of up to 24% in 48 weeks. MyPeptide.eu delivers Retatrutide to Luxembourg in 1-2 business days, with discreet packaging and an HPLC ≥99% certificate from Janoshik Analytical.
Why choose MyPeptide.eu for Retatrutide in Luxembourg?
- Purity ≥99% HPLC — Certified by the independent laboratory Janoshik Analytical
- COA per batch — Certificate of analysis available before purchase, verifiable online
- Delivery to Luxembourg — Ships in 1-2 business days from Europe, discreet packaging
- Stable freeze-dried — Most stable form for transport and storage
- Support in French and English — Team available via the contact page
What is Retatrutide?
Retatrutide (R3) is a triple agonist of the GLP-1, GIP, and Glucagon receptors. Developed by Eli Lilly, it outperforms semaglutide and tirzepatide in comparative studies of body weight and visceral fat reduction. It is available in lyophilized form with ≥99% HPLC purity for scientific research.
Delivery to Luxembourg
MyPeptide.eu ships Retatrutide to Luxembourg within 1-2 business days from Europe. Orders are shipped in discreet packaging, with no indication of the contents.
FAQ
Is Retatrutide legal in Luxembourg?
Research peptides are legally marketable in Luxembourg for scientific laboratory use. They are not intended for human consumption.
What is the delivery time to Luxembourg?
Delivery to Luxembourg usually takes 1-2 working days from Europe.
What is the purity of Retatrutide MyPeptide?
All our peptides have an HPLC purity ≥99%, certified by Janoshik Analytical. The Certificate of Analysis (COA) is available on the product page.
Delivery & Availability — Luxembourg
Delivery to Luxembourg (Luxembourg City, Esch-sur-Alzette) within 48-72 hours from the EU. No customs formalities. Retatrutide is available for scientific research in Luxembourg in accordance with European regulations on research peptides.
MyPeptide.eu supplies Luxembourg research teams working on metabolic modulation and GLP-1 agonists.
